Sage Journals: Discover world-class research

Abstract

Background

Major depressive disorder and bipolar disorder in adolescents are prevalent and are associated with cognitive impairment, executive dysfunction, and increased mortality. Early intervention in the initial stages of major depressive disorder and bipolar disorder can significantly improve personal health.

Methods

We collected 309 samples from the Adolescent Brain Cognitive Development study, including 116 adolescents with bipolar disorder, 64 adolescents with major depressive disorder, and 129 healthy adolescents, and employed a support vector machine to develop classification models for identification. We developed a multimodal model, which combined functional connectivity of resting-state functional magnetic resonance imaging and four anatomical measures of structural magnetic resonance imaging (cortical thickness, area, volume, and sulcal depth). We measured the performances of both multimodal and single modality classifiers.

Results

The multimodal classifiers showed outstanding performance compared with all five single modalities, and they are 100% for major depressive disorder versus healthy controls, 100% for bipolar disorder versus healthy control, 98.5% (95% CI: 95.4–100%) for major depressive disorder versus bipolar disorder, 100% for major depressive disorder versus depressed bipolar disorder and the leave-one-site-out analysis results are 77.4%, 63.3%, 79.4%, and 81.7%, separately.

Conclusions

The study shows that multimodal classifiers show high classification performances. Moreover, cuneus may be a potential biomarker to differentiate major depressive disorder, bipolar disorder, and healthy adolescents. Overall, this study can form multimodal diagnostic prediction workflows for clinically feasible to make more precise diagnose at the early stage and potentially reduce loss of personal pain and public society.

Keywords

Bipolar disorder major depressive disorder multimodal support vector machine cuneus

Introduction

Psychiatric disorders, such as major depressive disorder (MDD) and bipolar disorder (BD), are prevalent and detrimental in adolescents,^1–3 with a high degree of current and lifetime comorbidities partly due to common etiologies.^4,5 BD is one of the most severe and disabling psychiatric conditions affecting youth, significantly impairing an individual's ability to have relationships with family and friends, function at school, and cope with everyday life.⁶ Clinically, the diagnosis of psychiatry disorders mainly relies on the clinician's subjective assessment of the patient's complaints and symptoms. Strikingly, it is estimated that approximately 69% of patients with BD are initially misdiagnosed as MDD,⁷ which subsequently leads to inappropriate treatment, exacerbated manic symptoms, worse prognosis, increased health-care costs, and serious adverse events such as increased suicidality.^8,9 This is probably because depressive episodes are the most common mood manifestation, although BD consists of recurring episodes of mania/hypomania and depression.^10,11 Furthermore, childhood- or adolescent-onset are more severe than adult-onset, that is, more prolonged course, worse treatment effect, and more recurrences.¹² Unfortunately, children are often unable to articulate their feelings.¹³ Hence, differentiating between BD and MDD in children presents a unique clinical and research challenge. Successfully classification of these two disorders will not only aid diagnostic decisions but also provides insight into their etiology and neuropathological processes.

Recently, researchers have been trying to explore promising neurobiological markers to help identify affective disorders. Accumulating evidence suggests brain magnetic resonance imaging (MRI) presented distinct structural and functional features between healthy individuals and patients with MDD and BD.^14–17 A study on distinguishing bipolar and major depressive disorders by brain structural morphometry demonstrated distinct spatially distributed variations in cortical thickness and surface area in patients with BD and MDD.¹⁸ Compared to controls, a larger surface area in the temporo-parietal regions was observed in BD patients, and thinner cortices in fronto-temporal regions were observed in MDD patients, especially in the medial orbito-frontal area. Another study showed that gray matter volume in the right hippocampus, amygdala, parahippocampal, fusiform gyrus, and insula were reduced in BD patients compared with MDD. The volumes of the aforementioned regions and anterior cingulate cortex were also reduced in BD compared with healthy controls (HC).¹⁹ Current neuroimaging studies are often based on functional connectivity (FC) of functional MRI (fMRI) or anatomical features of structural MRI (sMRI). Brain anatomical features are highly biological heterogeneity, complicating the functional connectivity of patients with psychiatric disorders,^20,21 and two modalities complement each other. The developed machine learning (ML) methods made it possible to translate neuroimaging findings from the research field to clinical practice for diagnosis by providing individual-level classification.²² Support vector machine (SVM) is useful for high-dimensional and small sample data^23,24 and is one of the most widely used algorithms in diagnostic classification.²⁵ SVM was used to classify BD and HC with 100% accuracy.²⁶ In addition, The extensive implementation of ML algorithms on neuroimaging data has gradually identified some markers of psychiatric disorders. A meta-analysis explored the performance of different markers and ML algorithms in classifying several psychiatric disorders and found that the most discriminative features included gray and white matter alterations in the cortico-limbic region, and fMRI activations in this region during emotional tasks.²⁵ The combination of ML algorithms and neuroimaging data provides objective and reliable analysis, making a growing number of researchers recognize their contribution to psychiatric disorder diagnoses.²⁷

Despite these efforts, research on direct comparisons of neuroimaging measures between BD and MDD in youth is sparse and has shown inconclusive and inconsistent findings. Firstly, many neuroimaging studies on MDD and BD patients enrolled adult populations, not youths. It may be related to the difficulty in obtaining neuroimaging data of children. Exploring the changes in brain structures and functions in adolescents with MDD and BD is critical for finding early disease biomarkers and taking timely intervention. Early attention to the abnormality of brain functions and structures in adolescents is of great significance for the study of brain development and affective disorders. Secondly, most previous studies used a single modality in classification tasks.^23,28 Previous reports have shown multimodal models can produce higher classification accuracy, allowing the exploration of the abnormalities of brain structures and functions from multiple perspectives in MDD and BD patients. Thirdly, most of the existing studies are small sample studies (with a sample size of less than 200), which is far from reaching reliable²⁹ and consistent³⁰ conclusions. Biomarkers obtained by analyzing the MRI data from only a dozen subjects are also unreliable and usually need to be validated on larger samples. Simultaneously, the sample size will also affect the performance of the model. The small sample size makes the model unable to be fully trained and easily leads to overfitting. A larger sample size will help improve the stability and robustness of the model, thereby enhancing the reliability of the conclusions drawn. Moreover, the images collected by a single site in most studies made the model generalization ability weak and not easy to be extended to new clinical sites.

To address this gap, the study aimed to develop a high-performance differential diagnosis classifier for MDD and BD based on the data from the Adolescent Brain Cognitive Development (ABCD) study. We developed multimodal models covering five MRI modalities, including functional connectivity of fMRI and cortical thickness, area, volume, and sulcal depth of sMRI. We employed a modality-wise comparison of multimodal and single modality models to obtain the best classifiers. Finally, we discussed a biomarker that can distinguish adolescents with MDD and BD from healthy adolescents based on the best classifiers.

Methods

Dataset and participants

The data used in this study were obtained from the ABCD Data Release 3.0 (https://nda.nih.gov/abcd). The ABCD study is a large longitudinal study of the brain, behavioral development, and child health in the United States, recruiting more than 11,000 adolescent children aged between 9 and 10 years from 21 research sites across the USA.³¹ Written and oral informed consents from parents and children have been obtained, respectively.³² More information is provided at the ABCD website (https://abcdstudy.org) and elsewhere.³³

In this study, a total of 309 adolescents neuroimaging and demographic data who completed baseline tasks, including 116 BD, 64 MDD, and 129 healthy adolescents, were recruited for this study. The diagnoses of BD and MDD complied with the ABCD youth Diagnostic Interview for Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) (abcd_ksad501). According to the ABCD Parent Diagnostic Interview for DSM-5 Background Items (KSADS-5), 10 and 3 adolescents with MDD and 17 and 9 adolescents with BD had a history of hospitalization and medication in this study, respectively. Only participants with current MDD or BD, whose imaging data meet MRI Quality Control criteria (abcd_imgincl01) entered the study. We excluded the subjects in case of the following conditions, serious neurological or psychiatric diagnosis, and any traumatic brain injury (TBI). Cognitive function was assessed by the ABCD Youth NIH TB Summary Scores (abcd_tbss01), which consist of 10 validated and reliable psychometric test scores.

Imaging data acquisition and processing

All imaging was collected using a 3T scanner and the neuroimaging parameters are available: https://abcdstudy.org/images/Protocol_Imaging_Sequences.pdf. The ABCD Data Analysis and Information Center (DAIC) performed a series of standard preprocessing pipelines. More details on rs-fMRI and sMRI preprocessing steps and parameters are described in the Supplemental Method.

Details of ABCD neuroimaging data acquisition and processing methods have been previously published.^33,34 For rs-fMRI data, the time courses of each region of interest (ROI) obtained by preprocessing are sampled onto the FreeSurfers' cortical surface to calculate the average time course of each ROI. We used 13 predefined networks (e.g. default, fronto-parietal, dorsal attention, etc.) within the Gordon parcellation to calculate the Pearson correlation value of each pair of ROIs, which are Fisher transformed to z-statistics and averaged within or between networks to provide summary measures of network correlation strength. For sMRI data, the Desikan atlas was used to segment cortical regions into 68 ROIs for the whole brain after cortical reconstruction,³⁵ and the morphological values were measured including cortical thickness, area, volume, and sulcal depth. Finally, a total of 363 features were used as input data for the classification task, including 91 functional connectivity of rs-fMRI (13 within-network and 78 between-network) and 68 brain regions in every modality of sMRI.

Feature selection

Feature selection is necessary to avoid overfitting and the influence of redundant noise.^36–38 The recursive feature elimination (RFE) algorithm based on SVM was used to implement this process. RFE is an effective feature selection algorithm that uses the accuracy yielded by SVM to determine which features contribute most to the prediction results.^37,39,40 Training on the original, each feature was assigned a weight coefficient, and those features with the most negligible absolute weight were kicked out of the feature set. After multiple iterations, the features of small weight coefficients were removed until the remaining features reached optimal performance.

The feature selection process was embedded into the main prediction pipeline. The features required to achieve the highest accuracy via 10-fold stratified cross-validation were used as input to the model. This process was achieved by characterizing the learning curve of SVM-RFE, which shows the accuracy corresponding to the number of selected features by the weight vector of 10-fold stratified cross-validation. As a comparison, we measured model prediction performance without RFE.

SVM classification and evaluation

Synthetic Minority Oversampling Technique with Tomek link (SMOTETomek),^41–43 a method that combines over- and under-sampling, was implemented to correct the impacts of imbalanced data. We selected the linear kernel of SVM,^24,44 which could yield the feature importance to the classification. In addition, there is only one parameter C in linear kernel SVM,⁴³ which reflects the tolerance of the model to the classification error and is used to balance between the correct classification of training samples and the maximization of the margin of the decision boundary. In this study, we set the hyper-parameter C to the default value of 1, as previous reported.^43–45

Model performances were measured with standard metrics including accuracy, sensitivity, specificity, AUC (Area Under Curve), F1-score, positive predictive value (PPV), and negative predictive value (NPV), which are measured by 10-fold stratified cross-validation. The images in this study are from multiple sites, thus we perform a leave-one-site-out (LOSO) analysis embedded with 10-fold stratified cross-validation to test the site effects of 21 sites to verify the model's generalization. Specifically, an entire site was excluded from each round and the remaining 20 sites were used as the training set for feature selection. The hold-out site as the test set is used to calculate the performance by the important features selected from the training set to test the generalizability of these features in the new site. Site effect is considered significant if the 95% CI for the performance of any hold-out site does not overlap with other sites.^46,47

Statistical analysis

A linear model was employed to correct the feature values of fMRI and sMRI. This process was implemented in R statistical software version 3.6.1 (https://cran.r-project.org). All continuous variables were normalized to the standard normal distribution to avoid the influence of non-uniform dimensions. The aforementioned procedures were implemented on Python version 3.8.6 (https://www.python.org). Analysis of variance and χ² test were used for continuous and categorical measures, respectively. A two-sided P-value less than 0.05 was considered statistically significant.

Results

Demographic and clinical characteristics

Table 1 lists the demographic and clinical characteristics of the three groups. Our data analysis included 64 MDD adolescents, 116 BD adolescents, and 129 healthy controls. Data in the study were baseline data at enrollment. Participants did not differ significantly in age, gender, hand dominance, and medication history, but there were significant differences in standard intelligence scores, ethnicity, and hospitalization history. Given the significant difference in standard intelligence scores, ethnicity, and hospitalization history, we regressed these variables, along with other potentially confounding variables (including gender, age, and medication history) from neuroimaging features by linear models to eliminate confounding effects.^48,49

Table 1.

Demographic and clinical characteristics of participants.

	BD (n = 116)	MDD (n = 64)	HC (n = 129)	P-value
Demographic variables
Age, years	9.94 ± 0.63	9.89 ± 0.67	9.81 ± 0.55	0.28^a
Female	51 (43.97)	24 (37.50)	67 (51.94)	0.14^b
Left-handed	10 (8.62)	4 (6.25)	7 (5.43)	0.60^b
Standard intelligence Score	89.17 ± 10.87	87.16 ± 12.02	91.46 ± 11.00	<0.05 ^a
Ethnicity				<0.05 ^b
White	51 (43.97)	24 (37.50)	68 (52.71)
Black	32 (27.59)	22 (34.38)	19 (14.73)
Hispanic	20 (17.24)	11 (17.19)	30 (23.26)
Asian	–	-	3 (2.33)
Other	13 (11.21)	7 (10.94)	9 (6.98)
Clinical variables
Self-report
Hospitalization history	17 (14.66)	10 (15.63)	–	<0.05 ^b
Medication history	9 (7.76)	3 (4.69)	–	0.63^b
BD-I	40 (34.48)	–	–
manic	22 (18.97)	–	–
depressed	17 (14.67)	–	–
hypomanic	1 (0.86)	–	–
BD-II	22 (18.97)	–	–
depressed	18 (15.52)	–	–
hypomanic	4 (3.45)	–	–
BD-NOS	54 (46.55)	–	–
MDD	–	–	–
Present	–	43 (67.19)	–
partial remission	–	21 (32.81)	–

Data are expressed as n (%) or mean ± standard deviations. Bold represents statistically significant differences.

BD: bipolar disorder; BD-I: bipolar I disorder; BD-II: bipolar II disorder; BD-NOS: unspecified bipolar and related disorder; HC: healthy controls; MDD: major depressive disorder.

P-value was obtained from ANOVA analysis.

P-value was obtained from χ²-test

Feature importance

The optimal number of input features is 19–64 for five single modality classifiers achieving the highest accuracy, and more features are required, 34–102 features for multimodal classifiers, see Figure 1 and Supplemental Figure 1. The feature selection process significantly improved prediction performance.

Figure 1.

The learning curves of the multimodal classifiers in the 10-fold stratified cross-validation SVM-RFE algorithm. The x-axis shows the numbers of selected features, and the y-axis shows the corresponding accuracy.

The top-ten features of the multimodal SVM classifier are shown in Figure 2, while others are in Supplemental Tables 2 and 3. Cuneus is the only overlapping region among the top-ten features in the multimodal classifier, which was also found when distinguishing depressed BD patients from depressed MDD patients. This indicates that cuneus may be a potential biomarker to differentiate MDD, BD, and healthy adolescents.

Figure 2.

The top-ten features of multimodal classifiers in different classification tasks. The x-axis represents the feature's weight coefficient, and the y-axis represents the feature name. The average weight coefficient of each feature is determined by 10-fold cross-validation in SVM. Positive and negative coefficients represent positive and negative correlations. The higher the absolute value of the feature coefficient, the more significant impact of the feature on the model classification results.

The feature selection improved the performances of all modality classifiers, see Figure 3. The accuracies were significantly improved from 51.8–80.0% to 98.5–100% in multimodal classifiers and increased moderately from 45.4–74.6% to 66.5–86.9% in five single modalities, as shown in Supplemental Tables 4 and 5.

Figure 3.

Performance comparison between without and with feature selection.

Comparing the performance of all classifiers based on feature selection, multimodal classifiers yielded the highest scores than others (Table 2). The multimodal performances greatly exceed the chance level of 50%, as well as the clinically relevant threshold of 80%.^44,50,51 The receive operating characteristic (ROC) curves and the area under the curve (AUC) are presented in Figure 4, and the confusion matrix is illustrated in Figure 5.

Figure 4.

Receiver operating characteristic curves diagram of multimodal and single modality classifiers.

Figure 5.

Confusion matrix for multimodal classifiers.

Table 2.

Performance comparison between multimodal and single modality classifiers based on RFE-SVC feature selection.

	Multimodal	Single modality
	Multimodal	FC/rs-fMRI	CV/sMRI	CT/sMRI	CSD/sMRI	CA/sMRI
MDD versus HC	1.0(1.0–1.0)	0.833(0.783–0.885)	0.79(0.736–0.838)	0.856(0.808–0.902)	0.832(0.786–0.879)	0.809(0.752–0.859)
BD versus HC	1.0(1.0–1.0)	0.781(0.742–0.817)	0.761(0.696–0.825)	0.665(0.624–0.698)	0.697(0.661–0.735)	0.721(0.661–0.78)
MDD versus BD	0.985(0.954–1.0)	0.859(0.801–0.918)	0.784(0.715–0.854)	0.827(0.769–0.887)	0.859(0.815–0.901)	0.793(0.716–0.871)
MDD versus dBD	1.0(1.0–1.0)	0.81(0.71–0.9)	0.799(0.72–0.88)	0.847(0.783–0.907)	0.839(0.758–0.92)	0.869(0.809–0.93)

Data are classification accuracy (95% confidence intervals generated from 1000 bootstrap samples).

rs-fMRI: resting-state functional magnetic resonance imaging; sMRI: structural magnetic resonance imaging; BD: bipolar disorder; dBD: depressed bipolar disorder; MDD: major depressive disorder; HC: healthy controls; FC: functional connectivity; CV: cortical volume; CT: cortical thickness; CSD: cortical sulcal depth; CA: cortical area.

Sensitivity analyses

Finally, the LOSO analysis results are shown in Supplemental Figure 2. The site effect was not significant at 21 sites.

Discussion

The classification models used in this study to distinguish MDD, BD, and healthy adolescents were developed by 10-fold stratified cross-validation based on RFE-SVM. The accurate classifications of psychiatric disorders in adolescents based on neuroimaging are mainly attributed to the effect of multimodal. We regressed the confounding effects of latent variables using linear models and used the SMOTETomek algorithm to balance the sample size between groups to ensure fair and reliable results. Moreover, we found differences in the predictor required by several classifiers for accurate diagnosis. ML brings neuroimaging analyses to individual subject levels and allows prognostic formulation and treatment prescriptions to be tailored to the individual profile.

Accumulated MRI research studies have gradually improved the performance of machine learning algorithms in adult psychiatric disorder classification. Furthermore, the application of multimodal features has greatly improved model performance because multimodal features can provide multi-view information more than a single modality. A study achieved a high accuracy of 92.1% for distinguishing MDD and BD by using a multimodal method that combines the fractional amplitude of low-frequency fluctuations (fALFFs) of rs-fMRI and the gray matter volume of sMRI.²⁴ However, this conclusion was based on adult data and has not been validated in children and adolescents. Our multimodal models were constructed based on the adolescent neuroimaging data and obtained superior performance.

The functional and morphological abnormalities of the MDD and BD patients may be reflected in multiple brain regions and morphologies, so the classification performances of five single modality classifiers are slightly inferior. A study used the single modality of sMRI (gray matter volume) to classify BD and MDD with 75% accuracy.⁵² Another study used SVM of Elastic Net feature selection to classify MDD and HC on functional connectivity, and obtained 76.1% accuracy.⁵³ Our study achieved slightly higher performance in the same modality and classification task; that is, 78.4% accuracy uses cortical volume to distinguish MDD and BD, and 83.3% accuracy uses fMRI to distinguish MDD and HC. But it should also be noted that our study focused on populations and brain regions, unlike the above two studies. Grotegerd et al.⁴⁵ used fMRI to distinguish between unipolar and bipolar depression (bipolar: 10, unipolar: 10, control: 10) with nearly 90% accuracy. However, the small sample size makes the model unable to be fully trained and easily leads to overfitting, which in turn reduces the stability of the model and the reliability of the conclusion.

In terms of single modality, we did not find any single modality classifier to overperform other classifiers in classifying MDD, BD, and HC. Claude et al.⁵⁴ speculated that the classification performances based on fMRI might outshine sMRI. In distinguishing between MDD and BD patients, six studies using sMRI as the input features obtained accuracies ranging from 54.76% to 75.9%,^{18,39,52,55–57} compared with 67% to 93.1% in nine fMRI-based studies.^{18,45,58–64}

Cuneus may be a potential predictor, which to some certain extent sheds light on the physiological mechanism of MDD and BD. We found that the weight coefficients for cuneus were considerably high for all classifiers. The cuneus is associated with inhibitor control and motor response,⁶⁵ which is part of the default mode network (DMN), and its abnormal activation is related to depression. The greater activation of the right cuneus cortex at baseline is associated with a more remarkable improvement in the symptoms of depression and anxiety.^66,67 A global meta-analysis confirmed that the activation of the right cuneus was increased in patients with MDD.⁶⁸ Some evidence suggests that individuals with or at risk for depression are associated with structural alterations in the cuneus.^69–71 Previous studies have reported that cuneus gray matter volume is associated with depression⁷² and suicidal behavior^73,74 in MDD adults. Kim et al.⁷⁵ found that MDD adolescents have a thinner cortical thickness in the cuneus. In addition, two positron emission tomography (PET) studies both show that the metabolic activity of the right cuneus is positively correlated with the severity of apathy,^76–78 which is defined as a negative emotion with decreased feeling, and interest and attention.⁷⁷ Recognizing biomarkers can more timely and accurately diagnose MDD and BD, help individualized treatment and treatment response prediction, and provide the possibility for distinguishing subtypes of MDD and BD.³

Multimodal features provide rich brain functional and anatomical information, enabling the model to perform well. It is also vital that RFE-SVM select the best predictive features for multiple classification models. In addition, we used LOSO to internally validate the development of several multimodal models. We achieved about 70% accuracy in the LOSO analysis and close to 100% in the aggregate 10-fold cross-validation. In our study, perhaps due to the lack of prior knowledge of the test site,⁷⁹ LOSO classification accuracy is somewhat lower than that of all site's aggregate classification. Similarly, an ENIGMA study, which collected MRI data from 13 sites, yielded 58.67% mean accuracy in the LOSO analyses and 65.23% in aggregate 10-fold cross-validation in classifying bipolar and healthy participants.⁴³ Importantly, our research focuses on adolescents, which is conducive to the early identification of potential high-risk MDD and BD individuals and is essential for early diagnosis and treatment during childhood or adolescence.

This study has limitations and also potential for expansion. Our findings are based primarily on cortical regions, excluding subcortical regions, such as the hippocampus, amygdala, and thalamus, which have been identified as being associated with psychiatric disorders.^80,81 The sample size of this study was modest, and further large-high-quality training datasets from multi-site and external validation are required to improve the generalization of the diagnostic model. Moreover, as a complex disease, multi-omics studies are needed to consider the inclusion of more dimensional predictors such as demographic and clinical variables, genes, blood, and cognition.

Conclusion

In this adolescent study, we combined the functional connectivity of fMRI and four anatomical measurement values of sMRI (cortical thickness, area, volume, and sulcal depth) to build multimodal models. On this basis, we have developed several classification models with high accuracy and good generalization, which can form multimodal diagnostic prediction workflows for clinically feasible and individual-level predictions in MDD and BD adolescents.

Supplemental Material

sj-docx-1-dhj-10.1177_20552076221123705 - Supplemental material for Distinguish bipolar and major depressive disorder in adolescents based on multimodal neuroimaging: Results from the Adolescent Brain Cognitive Development study^®

Supplemental material, sj-docx-1-dhj-10.1177_20552076221123705 for Distinguish bipolar and major depressive disorder in adolescents based on multimodal neuroimaging: Results from the Adolescent Brain Cognitive Development study^® by Yujun Liu, Kai Chen, Yangyang Luo, Jiqiu Wu, Qu Xiang, Li Peng, Jian Zhang, Weiling Zhao, Mingliang Li and Xiaobo Zhou in Digital Health

Footnotes

Acknowledgements

Data used in the preparation of this article were obtained from the Adolescent Brain Cognitive Development^SM (ABCD) Study (https://abcdstudy.org), held in the NIMH Data Archive (NDA). This is a multisite, longitudinal study designed to recruit more than 10,000 children aged 9–10 and follow them over 10 years into early adulthood. The ABCD Study® is supported by the National Institutes of Health and additional federal partners under award numbers U01DA041048, U01DA050989, U01DA051016, U01DA041022, U01DA051018, U01DA051037, U01DA050987, U01DA041174, U01DA041106, U01DA041117, U01DA041028, U01DA041134, U01DA050988, U01DA051039, U01DA041156, U01DA041025, U01DA041120, U01DA051038, U01DA041148, U01DA041093, U01DA041089, U24DA041123, U24DA041147. A full list of supporters is available at https://abcdstudy.org/federal-partners.html. A listing of participating sites and a complete listing of the study investigators can be found at . ABCD consortium investigators designed and implemented the study and/or provided data but did not necessarily participate in the analysis or writing of this report. This manuscript reflects the views of the authors and may not reflect the opinions or views of the NIH or ABCD consortium investigators.

Contributorship

YJL and LP researched literature and conceived the study. YJL and KC involved in data analysis. YJL, YYL, JQW, KC, QX, LP, MLL, and JZ involved in clinical investigation and data curation. YJL wrote the first draft of the manuscript. WLZ, YYL, JQW, KC, and JZ involved manuscript proofreading. XBZ supervised overall implementation. All authors reviewed and edited the manuscript and approved the final version of the manuscript.

Declaration of conflicting interests

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Ethics approval

The study was reviewed and approved by the West China Hospital of Sichuan University Institutional Review Board.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the 1.3.5 project for disciplines of excellence–Clinical Research Incubation Project, West China Hospital, Sichuan University, Center of Excellence-International Collaboration Initiative Grant, West China Hospital, Sichuan University (grant nos. 2019HXFH022, 139170052).

Guarantor

YJL.

ORCID iD

Yujun Liu

Supplemental material

Supplemental material for this article is available online.

References

Cichon

Janas-Kozik

Siwiec

, et al. Clinical picture and treatment of bipolar affective disorder in children and adolescents. Psychiatr Pol 2020; 54: 35–50.

Zhou

Liu

Lan

, et al. Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents. Mol Psychiatry 2019; 24: 1478–1488.

Lee

H-J

Kim

Lee

. Understanding mood disorders in children. Singapore: Springer, 2019, pp. 251–261.

Rice

Riglin

Lomax

, et al. Adolescent and adult differences in major depression symptom profiles. J Affect Disord 2019; 243: 175–181.

Benazzi

. Bipolar disorder-focus on bipolar II disorder and mixed depression. The Lancet 2007; 369: 935–945.

Bilska

Pawlak

Kapelski

, et al. Differences in the clinical picture in women with a depressive episode in the course of unipolar and bipolar disorder. J Clin Med 2021; 10: 676. DOI: 10.3390/jcm10040676

Hirschfeld

Calabrese

Weissman

, et al. Screening for bipolar disorder in the community. J Clin Psychiatry 2003; 64: 53–59.

Kelberman

Biederman

Green

, et al. Differentiating bipolar disorder from unipolar depression in youth: a systematic literature review of neuroimaging research studies. Psychiat Res-Neuroim 2021; 307: 111201. DOI: ARTN 111201 10.1016/j.pscychresns.2020.111201

de Almeida

JRC

Phillips

. Distinguishing between unipolar depression and bipolar depression: current and future clinical and neuroimaging perspectives. Biol Psychiat 2013; 73: 111–118.

10.

Hirschfeld

. Differential diagnosis of bipolar disorder and major depressive disorder. J Affect Disord 2014; 169: S12–S16.

11.

Hashimoto

. Metabolomics of major depressive disorder and bipolar disorder: overview and future perspective. Adv Clin Chem 2018; 84: 81–99.

12.

Dunn

Goodyer

. Longitudinal investigation into childhood- and adolescence-onset depression: psychiatric outcome in early adulthood. Br J Psychiatry 2006; 188: 216–222.

13.

Lee

Kim

Lee

. Understanding mood disorders in children. Adv Exp Med Biol 2019; 1192: 251–261.

14.

Bani-Fatemi

Tasmim

Graff-Guerrero

, et al. Structural and functional alterations of the suicidal brain: an updated review of neuroimaging studies. Psychiatry Res Neuroimaging 2018; 278: 77–91.

15.

Bracht

Jones

Muller

, et al. Limbic white matter microstructure plasticity reflects recovery from depression. J Affect Disord 2015; 170: 143–149.

16.

Chang

Womer

Edmiston

, et al. Neurobiological commonalities and distinctions among three Major psychiatric diagnostic categories: a structural MRI study. Schizophr Bull 2018; 44: 65–74.

17.

Sui

, et al. Co-altered functional networks and brain structure in unmedicated patients with bipolar and major depressive disorders. Brain Struct Funct 2017; 222: 4051–4064.

18.

Fung

Deng

Zhao

, et al. Distinguishing bipolar and major depressive disorders by brain structural morphometry: a pilot study. BMC Psychiatry 2015; 15: 98.

19.

Vai

Parenti

Bollettini

, et al. Predicting differential diagnosis between bipolar and unipolar depression with multiple kernel learning on multimodal structural neuroimaging. Eur Neuropsychopharmacol 2020; 34: 28–38.

20.

Gao

Calhoun

Sui

. Machine learning in major depression: from classification to treatment outcome prediction. CNS Neurosci Ther 2018; 24: 1037–1052.

21.

Wang

, et al. Uncovering intrinsic modular organization of spontaneous brain activity in humans. PLoS One 2009; 4: e5226.

22.

Squarcina

Castellani

Bellani

, et al. Classification of first-episode psychosis in a large cohort of patients using support vector machine and multiple kernel learning techniques. Neuroimage 2017; 145: 238–245.

23.

Cui

Cao

, et al. Identification of bipolar disorder using a combination of multimodality magnetic resonance imaging and machine learning techniques. BMC Psychiatry 2020; 20: 88.

24.

Jie

Zhu

, et al. Discriminating bipolar disorder from Major depression based on SVM-FoBa: efficient feature selection with multimodal brain imaging data. IEEE Trans Auton Ment Dev 2015; 7: 320–331.

25.

Colombo

Calesella

Mazza

, et al. Machine learning approaches for prediction of bipolar disorder based on biological, clinical and neuropsychological markers: a systematic review and meta-analysis. Neurosci Biobehav Rev 2022; 135: 104552.

26.

Besga

Termenon

Grana

, et al. Discovering Alzheimer’s disease and bipolar disorder white matter effects building computer aided diagnostic systems on brain diffusion tensor imaging features. Neurosci Lett 2012; 520: 71–76.

27.

Teixeira

Salem

Frey

, et al. Update on bipolar disorder biomarker candidates. Expert Rev Mol Diagn 2016; 16: 1209–1220.

28.

Achalia

Sinha

Jacob

, et al. A proof of concept machine learning analysis using multimodal neuroimaging and neurocognitive measures as predictive biomarker in bipolar disorder. Asian J Psychiatr 2020; 50: 101984.

29.

Delvecchio

Fossati

Boyer

, et al. Common and distinct neural correlates of emotional processing in bipolar disorder and Major depressive disorder: a voxel-based meta-analysis of functional magnetic resonance imaging studies. Eur Neuropsychopharmacol 2012; 22: 100–113.

30.

Han

De Berardis

Fornaro

, et al. Differentiating between bipolar and unipolar depression in functional and structural MRI studies. Prog Neuropsychopharmacol Biol Psychiatry 2019; 91: 20–27.

31.

Casey

Cannonier

Conley

, et al. The adolescent brain cognitive development (ABCD) study: imaging acquisition across 21 sites. Dev Cogn Neurosci 2018; 32: 43–54.

32.

Auchter

Hernandez Mejia

Heyser

, et al. A description of the ABCD organizational structure and communication framework. Dev Cogn Neurosci 2018; 32: 8–15.

33.

Hagler

Jr. Hatton

Cornejo

, et al. Image processing and analysis methods for the adolescent brain cognitive development study. Neuroimage 2019; 202: 116091.

34.

Thompson

Barch

Bjork

, et al. The structure of cognition in 9 and 10 year-old children and associations with problem behaviors: findings from the ABCD study’s baseline neurocognitive battery. Dev Cogn Neurosci 2019; 36: 100606.

35.

Desikan

Segonne

Fischl

, et al.

An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest

Neuroimage 2006; 31: 968–980.

36.

Chu

S-H

Lenglet

Schreiner

, et al. Anatomical biomarkers for adolescent major depressive disorder from diffusion weighted imaging using SVM classifier. 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). 2018.

37.

Sartori

Reckziegel

Passos

, et al. Volumetric brain magnetic resonance imaging predicts functioning in bipolar disorder: a machine learning approach. J Psychiatr Res 2018; 103: 237–243.

38.

Salvador

Radua

Canales-Rodriguez

, et al. Evaluation of machine learning algorithms and structural features for optimal MRI-based diagnostic prediction in psychosis. PLoS One 2017; 12: e0175683.

39.

Sacchet

Livermore

Iglesias

, et al. Subcortical volumes differentiate major depressive disorder, bipolar disorder, and remitted major depressive disorder. J Psychiatr Res 2015; 68: 91–98.

40.

Saeys

Inza

Larranaga

. A review of feature selection techniques in bioinformatics. Bioinformatics 2007; 23: 2507–2517.

41.

Chawla

Bowyer

Hall

, et al. SMOTE: synthetic minority over-sampling technique. J Artif Intell Res 2002; 16: 321–357.

42.

Lemaitre

Nogueira

Aridas

. Imbalanced-learn: a python toolbox to tackle the curse of imbalanced datasets in machine learning. J Mach Learn Res 2017; 18: 1–5.

43.

Nunes

Schnack

Ching

CRK

, et al. Using structural MRI to identify bipolar disorders – 13 site machine learning study in 3020 individuals from the ENIGMA bipolar disorders working group. Mol Psychiatry 2020; 25: 2130–2143.

44.

Hajek

Cooke

Kopecek

, et al. Using structural MRI to identify individuals at genetic risk for bipolar disorders: a 2-cohort, machine learning study. J Psychiatry Neurosci 2015; 40: 316–324.

45.

Grotegerd

Suslow

Bauer

, et al. Discriminating unipolar and bipolar depression by means of fMRI and pattern classification: a pilot study. Eur Arch Psychiatry Clin Neurosci 2013; 263: 119–131.

46.

Gevers

Majoie

van den Tweel

, et al. Acquisition time and reproducibility of continuous arterial spin-labeling perfusion imaging at 3T. AJNR Am J Neuroradiol 2009; 30: 968–971.

47.

Almeida

JRC

Greenberg

, et al. Test-retest reliability of cerebral blood flow in healthy individuals using arterial spin labeling: findings from the EMBARC study. Magn Reson Imaging 2018; 45: 26–33.

48.

Squarcina

Perlini

Peruzzo

, et al. The use of dynamic susceptibility contrast (DSC) MRI to automatically classify patients with first episode psychosis. Schizophr Res 2015; 165: 38–44.

49.

Squarcina

Dagnew

Rivolta

, et al. Automated cortical thickness and skewness feature selection in bipolar disorder using a semi-supervised learning method. J Affect Disord 2019; 256: 416–423.

50.

Savitz

Rauch

Drevets

. Clinical application of brain imaging for the diagnosis of mood disorders: the current state of play. Mol Psychiatry 2013; 18: 528–539.

51.

Thies

Truschke

Morrison-Bogorad

, et al. Consensus report of the working group on: molecular and biochemical markers of Alzheimer’s disease. Neurobiol Aging 1999; 20: 47.

52.

Rubin-Falcone

Zanderigo

Thapa-Chhetry

, et al. Pattern recognition of magnetic resonance imaging-based gray matter volume measurements classifies bipolar disorder and major depressive disorder. J Affect Disord 2018; 227: 498–505.

53.

Bhaumik

Jenkins

Gowins

, et al. Multivariate pattern analysis strategies in detection of remitted major depressive disorder using resting state functional connectivity. Neuroimage Clin 2017; 16: 390–398.

54.

Claude

Houenou

Duchesnay

, et al. Will machine learning applied to neuroimaging in bipolar disorder help the clinician? A critical review and methodological suggestions. Bipolar Disord 2020; 22: 334–355.

55.

Matsuo

Harada

Fujita

, et al. Distinctive neuroanatomical substrates for depression in bipolar disorder versus Major depressive disorder. Cereb Cortex 2019; 29: 202–214.

56.

Redlich

Almeida

Grotegerd

, et al. Brain morphometric biomarkers distinguishing unipolar and bipolar depression. A voxel-based morphometry-pattern classification approach. JAMA Psychiatry 2014; 71: 1222–1230.

57.

Serpa

Schaufelberger

, et al. Neuroanatomical classification in a population-based sample of psychotic major depression and bipolar I disorder with 1 year of diagnostic stability. Biomed Res Int 2014; 2014: 706157.

58.

Almeida

Mourao-Miranda

Aizenstein

, et al. Pattern recognition analysis of anterior cingulate cortex blood flow to classify depression polarity. Br J Psychiatry 2013; 203: 310–311.

59.

Das

Deng

, et al. Clinical utility of a short resting-state MRI scan in differentiating bipolar from unipolar depression. Acta Psychiatr Scand 2017; 136: 288–299.

60.

Rive

Redlich

Schmaal

, et al. Distinguishing medication-free subjects with unipolar disorder from subjects with bipolar disorder: state matters. Bipolar Disord 2016; 18: 612–623.

61.

Gao

Osuch

Wammes

, et al. Discriminating bipolar disorder from major depression based on kernel SVM using functional independent components. IEEE International workshop on machine learning for signal processing. Tokyo, 2017, p. 1–6.

62.

Burger

Redlich

Grotegerd

, et al. Differential abnormal pattern of anterior cingulate gyrus activation in unipolar and bipolar depression: an fMRI and pattern classification approach. Neuropsychopharmacology 2017; 42: 1399–1408.

63.

Grotegerd

Stuhrmann

Kugel

, et al. Amygdala excitability to subliminally presented emotional faces distinguishes unipolar and bipolar depression: an fMRI and pattern classification study. Hum Brain Mapp 2014; 35: 2995–3007.

64.

Mourao-Miranda

Almeida

Hassel

, et al. Pattern recognition analyses of brain activation elicited by happy and neutral faces in unipolar and bipolar depression. Bipolar Disord 2012; 14: 451–460.

65.

Matthews

Simmons

Arce

, et al. Dissociation of inhibition from error processing using a parametric inhibitory task during functional magnetic resonance imaging. Neuroreport 2005; 16: 755–760.

66.

Greicius

Supekar

Menon

, et al. Resting-state functional connectivity reflects structural connectivity in the default mode network. Cereb Cortex 2009; 19: 72–78.

67.

Marwood

Wise

Perkins

, et al. Meta-analyses of the neural mechanisms and predictors of response to psychotherapy in depression and anxiety. Neurosci Biobehav Rev 2018; 95: 61–72.

68.

Zhang

Chang

Guo

, et al. The neural correlates of reward-related processing in major depressive disorder: a meta-analysis of functional magnetic resonance imaging studies. J Affect Disord 2013; 151: 531–539.

69.

Qiu

Lui

Kuang

, et al. Regional increases of cortical thickness in untreated, first-episode major depressive disorder. Transl Psychiatry 2014; 4: e378.

70.

Yang

Zhang

Ahn

, et al. Development and evaluation of a multimodal marker of major depressive disorder. Hum Brain Mapp 2018; 39: 4420–4439.

71.

Dotson

Bogoian

Gradone

, et al. Subthreshold depressive symptoms relate to cuneus structure: thickness asymmetry and sex differences. J Psychiatr Res 2021; 145: 144–147.

72.

Kroes

Rugg

Whalley

, et al. Structural brain abnormalities common to posttraumatic stress disorder and depression. J Psychiatry Neurosci 2011; 36: 256–265.

73.

Overs

Roberts

Ridgway

, et al. Effects of polygenic risk for suicide attempt and risky behavior on brain structure in young people with familial risk of bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2021; 186: 485–507.

74.

Giakoumatos

Tandon

Shah

, et al.

Are structural brain abnormalities associated with suicidal behavior in patients with psychotic disorders?

J Psychiatr Res 2013; 47: 1389–1395.

75.

Kim

Suh

Lee

, et al. Cortical and subcortical gray matter alterations in first-episode drug-naive adolescents with major depressive disorder. Neuroreport 2019; 30: 1172–1178.

76.

Dujardin

Defebvre

. Apathy in Parkinson’s disease: what are the underlying mechanisms? Neurology 2012; 79: 1082–1083.

77.

Robert

Le Jeune

Lozachmeur

, et al. Apathy in patients with Parkinson disease without dementia or depression: a PET study. Neurology 2012; 79: 1155–1160.

78.

Voon

Howell

Krack

. Psychiatric considerations in deep brain stimulation for Parkinson’s disease. Brain Stimul 2013; 116: 147–154.

79.

Zhao

Huang

Zhi

, et al. Functional network connectivity (FNC)-based generative adversarial network (GAN) and its applications in classification of mental disorders. J Neurosci Methods 2020; 341: 108756.

80.

Li Hui Chong

Lee

, et al. The amygdala in schizophrenia and bipolar disorder: a synthesis of structural MRI, diffusion tensor imaging, and resting-state functional connectivity findings. Harv Rev Psychiatry 2019; 27: 150–164.

81.

Skatun

Kaufmann

Brandt

, et al. Thalamo-cortical functional connectivity in schizophrenia and bipolar disorder. Brain Imaging Behav 2018; 12: 640–652.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

2.73 MB

Distinguish bipolar and major depressive disorder in adolescents based on multimodal neuroimaging: Results from the Adolescent Brain Cognitive Development study ®

Abstract

Background

Methods

Results

Conclusions

Keywords

Introduction

Methods

Dataset and participants

Imaging data acquisition and processing

Feature selection

SVM classification and evaluation

Statistical analysis

Results

Demographic and clinical characteristics

Feature importance

Sensitivity analyses

Discussion

Conclusion

Supplemental Material

sj-docx-1-dhj-10.1177_20552076221123705 - Supplemental material for Distinguish bipolar and major depressive disorder in adolescents based on multimodal neuroimaging: Results from the Adolescent Brain Cognitive Development study®

Footnotes

Acknowledgements

Contributorship

Declaration of conflicting interests

Ethics approval

Funding

Guarantor

ORCID iD

Supplemental material

References

Supplementary Material

sj-docx-1-dhj-10.1177_20552076221123705 - Supplemental material for Distinguish bipolar and major depressive disorder in adolescents based on multimodal neuroimaging: Results from the Adolescent Brain Cognitive Development study^®